Introduction
Vaccination
Geographic
Health Hints
Index
|
REFERENCES
 | International Health Regulations (1969)
Third Annotated Edition, World Health Organization, Geneva, 1983
|
| International Travel and Health,
Vaccination Requirements and Health Advice—Situation as of 1 January 1996. World
Health Organization, Geneva, 1996
|
| Weekly Epidemiological Record-World
Health Organization, Geneva, 1995-1996
|
| Dengue—Hemorrhagic
Fever—Puerto Rico, MMWR 35:50, 1986
|
| Dengue and Dengue
Hemorrhagic Fever in the Americas, 1986, MMWR 37:7, 1988
|
| Travelers' Diarrhea, National Institutes
of Health Consensus Development Conference Statement. Volume 5 Number 8
|
| Recommendations of the Advisory
Committee on Immunization Practices (ACIP):
- Update on Adult Immunization: MMWR 40:RR-12,1991
- General Recommendations on Immunization, MMWR 43:1, 1994
- Cholera Vaccine, MMWR 37:40, 1988
- Diphtheria, Tetanus, and Pertussis: Recommendations of the ACIP for
Vaccine Use and other Preventive Measures, MMWR 40:RR-10, 1991
- Pertussis Vaccination: Acellular Pertussis Vaccine for Reinforcing and Booster
Use—Supplementary ACIP Statement, MMWR 41:RR-1, 1992
- Pertussis Vaccination: Acellular Pertussis Vaccine for the Fourth and Fifth Doses of the
DTP Series: Update to Supplementary ACIP Statement; Recommendations of the ACIP, MMWR
41:RR-15, 1992
- Haemophilus b Conjugate Vaccines, MMWR 40:RR-1,1991
- Haemophilus b Conjugate Vaccines and a Combined Diphtheria, Tetanus, Pertussis and
Haemophilus b Vaccine, MMWR 42:RR-13, 1993
- Protection against Viral Hepatitis, MMWR 39:RR-2, 1990
- Hepatitis B Virus: A Comprehensive Strategy for Eliminating Transmission In the United
States Through Universal Childhood Vaccination. MMWR 40:RR-13, 1991
- Use of Vaccine and Immune Globulins in Persons with Altered Immunocompetence, MMWR
42:RR-4, 1993
- Immunization of Children Infected with Human T-Lymphotropic Virus Type
III/Lymphadenopathy-Associated Virus, MMWR 35:38, 1986
- Immunization of Children Infected with Human Immunodeficiency Virus-Supplementary ACIP
Statement, MMWR 37:12, 1988
- Inactivated Japanese Encephalitis Virus Vaccine, MMWR 42:RR-1, 1993
- Measles Prevention, MMWR 38:S-9, 1989
- Meningococcal Vaccines, MMWR 34:18, 1985
- Mumps Vaccine, MMWR 38:22, 1989
- Plague Vaccine, MMWR 45:R-14, 1996
- Pneumococcal Polysaccharide Vaccine Usage—United States, MMWR 38:5, 1989
- Poliomyelitis Prevention, MMWR 31:3, 1982
- Poliomyelitis Prevention: Enhanced-Potency Inactivated Poliomyelitis
Vaccine— Supplementary Statement, MMWR 36:48, 1987
- Rabies Prevention — United States 1991, MMWR 40:RR-3, 1991
- Rubella Prevention, MMWR 39:RR-15, 1990
- Vaccinia (Smallpox) Vaccine, MMWR 40:RR-14, 1991
- Typhoid Vaccine, MMWR 43:RR-14, 1994
- Varicella-Zoster Immune Globulin for the Prevention of Chickenpox, MMWR 33:7,
1984
- Yellow Fever Vaccine, MMWR 39:RR-6, 1990
|
|
